EE9600011A - Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid - Google Patents

Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid

Info

Publication number
EE9600011A
EE9600011A EE9600011A EE9600011A EE9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A
Authority
EE
Estonia
Prior art keywords
pyridinyl
benzimidazole derivatives
dialkoxy
novel
novel dialkoxy
Prior art date
Application number
EE9600011A
Other languages
English (en)
Estonian (et)
Inventor
Lennart Lindberg Per
Oskar Sverker Von Unge Per
Elisabeth Sund�n Gunnel
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9600011A publication Critical patent/EE9600011A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9600011A 1994-05-27 1995-05-11 Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid EE9600011A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (fr) 1994-05-27 1995-05-11 Nouveaux derives de dialcoxy-pyridinyl-benzimidazole

Publications (1)

Publication Number Publication Date
EE9600011A true EE9600011A (et) 1996-04-15

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600011A EE9600011A (et) 1994-05-27 1995-05-11 Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid

Country Status (18)

Country Link
EP (1) EP0712401A1 (fr)
JP (1) JPH09504557A (fr)
CN (1) CN1128997A (fr)
AU (1) AU2633095A (fr)
BR (1) BR9506235A (fr)
CA (1) CA2166988A1 (fr)
CZ (1) CZ24396A3 (fr)
EE (1) EE9600011A (fr)
FI (1) FI960367A0 (fr)
HU (1) HU9600005D0 (fr)
IL (1) IL113604A0 (fr)
IS (1) IS4321A (fr)
MA (1) MA23563A1 (fr)
NO (1) NO960268L (fr)
PL (1) PL312692A1 (fr)
TN (1) TNSN95062A1 (fr)
WO (1) WO1995032959A1 (fr)
ZA (1) ZA954125B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
IL142629A0 (en) * 1998-11-18 2002-03-10 Astra Ab Improved chemical process and pharmaceutical formulation
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2008057802A2 (fr) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
CA2716367C (fr) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprenant une combinaison d'omeprazole et de lansoprazole, et un agent tampon, et ses methodes d'utilisation
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (fr) 2009-06-25 2016-11-01 Astrazeneca Ab Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649456B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
FI960367A7 (fi) 1996-01-26
CN1128997A (zh) 1996-08-14
JPH09504557A (ja) 1997-05-06
EP0712401A1 (fr) 1996-05-22
ZA954125B (en) 1995-11-27
HU9600005D0 (en) 1996-03-28
FI960367L (fi) 1996-01-26
MA23563A1 (fr) 1995-12-31
NO960268D0 (no) 1996-01-23
AU2633095A (en) 1995-12-21
NO960268L (no) 1996-01-23
TNSN95062A1 (fr) 1996-02-06
IL113604A0 (en) 1995-08-31
CZ24396A3 (en) 1996-06-12
BR9506235A (pt) 1997-08-12
CA2166988A1 (fr) 1995-12-07
WO1995032959A1 (fr) 1995-12-07
FI960367A0 (fi) 1996-01-26
IS4321A (is) 1996-01-17
PL312692A1 (en) 1996-05-13

Similar Documents

Publication Publication Date Title
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI954008L (fi) Substituoituja bifenyyli-isoksatsolisulfoniamideja
FI951908A7 (fi) Substituoituja pyridyylipyratsoleja
FI955927A7 (fi) Substituoidut 1H-imidatsolit
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
DE69534718D1 (de) Substituierte 9-alkyladenine
EP0708091A3 (fr) Dérivés d'indoloyl-guanidines
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (fi) Deasetoksitaksolijohdannaiset
NO970144D0 (no) Trifluormetylkinolinkarboksylsyre-derivat
KR950033309U (ko) 줄연장
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI963122L (fi) Karbamoyylimetyyliureajohdannaiset
BR9506613A (pt) Derivados de feniltio-oxazolinas